© Copyright - Newspaper WordPress Theme by TagDiv
Diltiazem Hydrochloride
Also known as / Synonyms: Diltiazem, Non-dihydropyridine calcium channel blocker
Non-dihydropyridine calcium channel blocker for angina, blood pressure control, and heart rate management in atrial fibrillation.
Clinical Snapshot & Specifications
Approved Indications & Medical Uses
- Management of chronic stable angina pectoris and vasospastic (Prinzmetal) angina.
- Essential hypertension (especially sustained-release formulations).
- Ventricular rate control in rapid atrial fibrillation or atrial flutter, and paroxysmal supraventricular tachycardia (PSVT).
Contraindications (Do Not Use If…)
- Sick sinus syndrome or second- or third-degree AV block (except with functioning ventricular pacemaker).
- Severe hypotension (systolic BP < 90 mmHg).
- Acute myocardial infarction with pulmonary congestion.
- Decompensated heart failure with reduced ejection fraction.
- Accessory bypass tract syndromes (Wolff-Parkinson-White syndrome) with atrial fibrillation.
Important Clinical Precautions & Warnings
- Bradycardia and AV block: slow conduction at AV node; monitor resting pulse and ECG.
- Hepatic and renal impairment: substantially metabolized by CYP3A4 in liver; adjust dosage.
- Heart failure: negative inotropic effect can worsen cardiac decompensation in low EF patients.
- Avoid concurrent intravenous beta-blockers due to additive negative inotropic and chronotropic collapse.
Special Populations (Paediatric & Geriatric Care)
Pediatric: Safety and efficacy in children have not been established. Elderly: May have higher peak concentrations and slower elimination; start with low doses.
Side Effects & Adverse Reactions
Common Side Effects (Usually Mild)
Peripheral edema (ankle swelling), headache, dizziness, bradycardia, AV block first-degree, flushing, fatigue, and nausea.
Serious Side Effects — Seek Urgent Medical Care
Profound bradycardia, complete heart block, cardiac arrest in WPW with AF, acute pulmonary edema, toxic epidermal necrolysis, and hepatotoxicity.
Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.
Drug, Food & Substance Interactions
- Beta-blockers: severe bradycardia, AV block, and cardiac depression.
- Digoxin: increases digoxin serum concentrations by 20–50%; monitor levels.
- CYP3A4 substrates (statins like simvastatin, atorvastatin): increases statin levels and myopathy risk.
- Cyclosporine: elevates cyclosporine levels leading to nephrotoxicity.
Pregnancy & Lactation Clinical Safety
Pregnancy Safety:
Use with caution — see notesUse only if the potential benefit justifies potential risk to the fetus; animal studies demonstrate skeletal malformations and embryo death.
Lactation & Breastfeeding:
Use with caution — see notesExcreted in human milk in concentrations roughly equal to maternal serum. Discontinue nursing or drug depending on clinical urgency.
Storage, Administration & Overdose Protocol
🌡️ Recommended Storage:
Store below 25°C in a dry place protected from light.
⏱️ Missed Dose Protocol:
Take standard tablets before meals and at bedtime; swallow sustained release tablets whole without crushing. If missed, take as soon as remembered.
Overdose causes profound bradycardia, hypotension, heart block, and cardiogenic shock. Treat with IV fluids, calcium chloride or gluconate, atropine, and vasopressors.
